Oral administration of L-C has been shown to help in lipid metabolism [9, 10], insulin-dependent glucose disposal, and blood pressure control [11]; suggesting a potential favorable influence on the cardiovascular risk factors associated with MetS. Here, INS is linked to metabolic syndrome.